SCHEMBL30810216

SCHEMBL30810216

COC(=O)c1cc(I)cc(CBr)c1OC

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.40
ALDH1A1 P00352 6/20 0.40
HPGD P15428 3/20 0.40
NPSR1 Q6W5P4 1/20 0.40
POLB P06746 2/20 0.40
HSD17B10 Q99714 2/20 0.37
USP2 O75604 1/20 0.37
HTT P42858 1/20 0.37
LMNA P02545 1/20 0.36
GAA P10253 2/20 0.35
GALK1 P51570 1/20 0.35
SOS1 Q07889 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
DRD2 P14416 1/20 0.34
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30810255 0.81 KDM4E (0.43) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL19612141 0.81 KDM4E (0.43) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL30810239 0.81 KDM4E (0.43) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL4123488 0.79 HSD17B10 (0.49) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL1530644 0.78 KDM4E (0.45) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL19810435 0.78 ALDH1A1 (0.41) KDM4EALDH1A1HPGDPOLBHSD17B10
SCHEMBL21618223 0.78 ALDH1A1 (0.44) KDM4EALDH1A1HPGDHSD17B10LMNA
SCHEMBL4871213 0.77 KDM4E (0.56) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL30810326 0.77 KDM4E (0.44) KDM4EALDH1A1HPGDNPSR1POLB
SCHEMBL4878432 0.77 KDM4E (0.44) KDM4EALDH1A1HPGDNPSR1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4583870-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER Mito Biopharma, LLC (US) 2025-07-16 EP disclosed
WO-2024054766-A2 MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER MITO BIOPHARMA, LLC (US) 2024-03-14 WO disclosed